Grifols, S.A. Sponsored ADR Class B GRFS 深 沪
已收盘 04-02 16:00:00 美东时间
8.24
-0.010
-0.12%
华盛通- 最 高8.25
- 今 开8.13
- 成交量 75.88万股
- 最 低 8.00
- 昨 收 8.25
- 总市值 56.08亿
- 52周最高 10.9976
- 市盈率 静 12.36
- 换手率 0.11%
- 52周最低 6.6926
- 委 比 -28.64%
- 总股本 6.81亿
- 历史最高 25.0846
- 量 比 1.04
- 振 幅 3.03%
- 历史最低 0.0779
- 每 手 1
- 风险率 1.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Grifols facing restrictions in Canada after plasma donor deaths
Canadian health officials imposed restrictions on all plasma centers run by Grifols (GRFS) after the Spanish company failed multiple regulatory inspections and following fatal adverse reactions in two...
今天 00:39
'Grifols' Canadian License Restricted After Plasma Donor Deaths' - Bloomberg
https://www.bloomberg.com/news/articles/2026-04-02/grifols-canadian-license-restricted-after-plasma-donor-deaths
04-02 23:46
Grifols considers IPO of part of its US biopharma business
Spanish pharma Grifols, S.A. (GRFS) said that its board has decided to evaluate a potential US IPO of its shares of its US biopharma business. The company said it was making the move as part of its "s...
03-25 05:40
Grifols expands AMBAR Alzheimer’s plasma exchange program with new clinics in Madrid, Mallorca and Alicante
Grifols expands AMBAR Alzheimer’s plasma exchange program with new clinics in Madrid, Mallorca and Alicante Grifols renewed its collaboration with Ace Alzheimer Center Barcelona to continue developing the AMBAR (Alzheimer Management by Albumin Replacement) clinical program and to expand the protocol
03-12 17:41
Spanish stocks - Factors to watch on March 4
Spanish stocks - Factors to watch on March 4 March 4 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: SANTANDER SAN.MC Santander's SAN.MC $12.2 billion ac
03-04 14:52
Grifols Expects Reaching Free Cash Flow Pre-M&A Pre-Dividends Of €500M-575M; 2027 Milestones Unchanged; 2026 Adjusted EBITDA Margin Of Over 25%
https://www.grifols.com/en/view-news/-/news/grifols-reports-revenues-of-eur-7524m-up-7-and-more-than-doubles-group-profit-to-eur-402m
02-27 00:48
Grifols SA Receives Moody’s B1 Rating with Stable Outlook
Grifols SA Receives Moody’s B1 Rating with Stable Outlook Grifols SA has received an upgrade to its corporate family rating from Moody’s Ratings, moving from B2 to B1 with a stable outlook. Moody’s also raised the probability of default rating to B1-PD from B2-PD, upgraded the instrument ratings of
02-16 23:28
Grifols Adjusts Board Secretariat Roles Effective January 1, 2026
Grifols SA ( ($GRFS) ) has shared an announcement. On January 8, 2026, Grifols,...
01-09 04:47
BRIEF-Grifols Gets FDA Approval For New Fibrinogen Concentrate, Fesiltytm
Dec 19 (Reuters) - Grifols SA GRLS.MC: RECEIVES US FDA APPROVAL FOR NEW FIBRINOGEN CONCENTRATE, FESILTYTM (FIBRINOGEN, HUMAN-CHMT) FESILTY EXPECTED TO BE AVAILABLE IN THE U.S. WITHIN THE FIRST HALF OF...
2025-12-19 19:12
